Metabolic and hepatic effects of liraglutide, obeticholic acid and elafbranor in diet-induced obese mouse models of biopsy-confrmed nonalcoholic steatohepatitis
World Journal of Gastroenterology 24(2):179–194, 2018
INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
World Journal of Gastroenterology 24(2):195–210, 2018
GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice
Journal of Peptide Science 23(12):845–854, 2017
In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes
European Journal of Pharmacology 815:181–189, 2017
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Drug Discovery Today 22(11):1707–1718, 2017
A hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist
ACS Chemical Biology 12(8):2107–2116, 2017
Neurturin and a GLP-1 analogue act synergistically to alleviate diabetes in Zucker diabetic fatty rats
Diabetes 66(7):2007–2018, 2017
Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia
Kidney International 92(1):165–178, 2017